BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12960827)

  • 1. Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda.
    Gray RH; Li X; Wawer MJ; Gange SJ; Serwadda D; Sewankambo NK; Moore R; Wabwire-Mangen F; Lutalo T; Quinn TC;
    AIDS; 2003 Sep; 17(13):1941-51. PubMed ID: 12960827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda.
    Gray RH; Li X; Kigozi G; Serwadda D; Nalugoda F; Watya S; Reynolds SJ; Wawer M
    AIDS; 2007 Apr; 21(7):845-50. PubMed ID: 17415039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Medical Male Circumcision and Antiretroviral Therapy Scale-up With Community HIV Incidence in Rakai, Uganda.
    Kong X; Kigozi G; Ssekasanvu J; Nalugoda F; Nakigozi G; Ndyanabo A; Lutalo T; Reynolds SJ; Ssekubugu R; Kagaayi J; Bugos E; Chang LW; Nanlesta P; Mary G; Berman A; Quinn TC; Serwadda D; Wawer MJ; Gray RH
    JAMA; 2016 Jul; 316(2):182-90. PubMed ID: 27404186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in HIV-1 prevalence may not reflect trends in incidence in mature epidemics: data from the Rakai population-based cohort, Uganda.
    Wawer MJ; Serwadda D; Gray RH; Sewankambo NK; Li C; Nalugoda F; Lutalo T; Konde-Lule JK
    AIDS; 1997 Jul; 11(8):1023-30. PubMed ID: 9223737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV Prevention Efforts and Incidence of HIV in Uganda.
    Grabowski MK; Serwadda DM; Gray RH; Nakigozi G; Kigozi G; Kagaayi J; Ssekubugu R; Nalugoda F; Lessler J; Lutalo T; Galiwango RM; Makumbi F; Kong X; Kabatesi D; Alamo ST; Wiersma S; Sewankambo NK; Tobian AAR; Laeyendecker O; Quinn TC; Reynolds SJ; Wawer MJ; Chang LW;
    N Engl J Med; 2017 Nov; 377(22):2154-2166. PubMed ID: 29171817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda.
    Bunnell R; Ekwaru JP; Solberg P; Wamai N; Bikaako-Kajura W; Were W; Coutinho A; Liechty C; Madraa E; Rutherford G; Mermin J
    AIDS; 2006 Jan; 20(1):85-92. PubMed ID: 16327323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of HIV-1 infection in a rural region of Uganda.
    Wawer MJ; Sewankambo NK; Berkley S; Serwadda D; Musgrave SD; Gray RH; Musagara M; Stallings RY; Konde-Lule JK
    BMJ; 1994 Jan; 308(6922):171-3. PubMed ID: 8312767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team.
    Gray RH; Wawer MJ; Sewankambo NK; Serwadda D; Li C; Moulton LH; Lutalo T; Wabwire-Mangen F; Meehan MP; Ahmed S; Paxton LA; Kiwanuka N; Nalugoda F; Korenromp EL; Quinn TC
    AIDS; 1999 Oct; 13(15):2113-23. PubMed ID: 10546865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional comparative study of risky sexual behaviours among HIV-infected persons initiated and waiting to start antiretroviral therapy in rural Rakai, Uganda.
    Nakiganda LJ; Nakigozi G; Kagaayi J; Nalugoda F; Serwadda D; Sewankambo N; Gray R; Ndyanabo A; Muwanika R; Asamoah BO
    BMJ Open; 2017 Sep; 7(9):e016954. PubMed ID: 28893749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study.
    Shafer LA; Nsubuga RN; Chapman R; O'Brien K; Mayanja BN; White RG
    Sex Transm Infect; 2014 Aug; 90(5):423-9. PubMed ID: 24567521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.
    Gray RH; Wawer MJ; Brookmeyer R; Sewankambo NK; Serwadda D; Wabwire-Mangen F; Lutalo T; Li X; vanCott T; Quinn TC;
    Lancet; 2001 Apr; 357(9263):1149-53. PubMed ID: 11323041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy.
    Reynolds SJ; Makumbi F; Nakigozi G; Kagaayi J; Gray RH; Wawer M; Quinn TC; Serwadda D
    AIDS; 2011 Feb; 25(4):473-7. PubMed ID: 21160416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.
    Blower S; Schwartz EJ; Mills J
    AIDS Rev; 2003; 5(2):113-25. PubMed ID: 12876900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based study of fertility in women with HIV-1 infection in Uganda.
    Gray RH; Wawer MJ; Serwadda D; Sewankambo N; Li C; Wabwire-Mangen F; Paxton L; Kiwanuka N; Kigozi G; Konde-Lule J; Quinn TC; Gaydos CA; McNairn D
    Lancet; 1998 Jan; 351(9096):98-103. PubMed ID: 9439494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the impact of universal antiretroviral therapy for HIV serodiscordant couples through home HIV testing: insights from mathematical models.
    Roberts ST; Khanna AS; Barnabas RV; Goodreau SM; Baeten JM; Celum C; Cassels S
    J Int AIDS Soc; 2016; 19(1):20864. PubMed ID: 27174911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda.
    Ratmann O; Kagaayi J; Hall M; Golubchick T; Kigozi G; Xi X; Wymant C; Nakigozi G; Abeler-Dörner L; Bonsall D; Gall A; Hoppe A; Kellam P; Bazaale J; Kalibbala S; Laeyendecker O; Lessler J; Nalugoda F; Chang LW; de Oliveira T; Pillay D; Quinn TC; Reynolds SJ; Spencer SEF; Ssekubugu R; Serwadda D; Wawer MJ; Gray RH; Fraser C; Grabowski MK;
    Lancet HIV; 2020 Mar; 7(3):e173-e183. PubMed ID: 31953184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts.
    Bellan SE; Dushoff J; Galvani AP; Meyers LA
    PLoS Med; 2015 Mar; 12(3):e1001801. PubMed ID: 25781323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus transmission at each step of the care continuum in the United States.
    Skarbinski J; Rosenberg E; Paz-Bailey G; Hall HI; Rose CE; Viall AH; Fagan JL; Lansky A; Mermin JH
    JAMA Intern Med; 2015 Apr; 175(4):588-96. PubMed ID: 25706928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of the HIV epidemic in agrarian, trading, and fishing communities in Rakai, Uganda: an observational epidemiological study.
    Chang LW; Grabowski MK; Ssekubugu R; Nalugoda F; Kigozi G; Nantume B; Lessler J; Moore SM; Quinn TC; Reynolds SJ; Gray RH; Serwadda D; Wawer MJ
    Lancet HIV; 2016 Aug; 3(8):e388-e396. PubMed ID: 27470029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the impact on HIV incidence of combination prevention strategies among men who have sex with men in Beijing, China.
    Lou J; Blevins M; Ruan Y; Vermund SH; Tang S; Webb GF; Shepherd BE; He X; Lu H; Shao Y; Qian HZ
    PLoS One; 2014; 9(3):e90985. PubMed ID: 24626165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.